In this randomized clinical trial, inclusion criteria are: having polygenic dyslipidemia as defined, not taking lipid lowering drugs and exclusion criteria are: having allergy to tea, not interested in consuming tea; having other diseases such as familial dyslipidemia, diabetes, cardiovascular disease, kidney and liver diseases. 50 patients after signing informed consent will be entered to the study. The patients will be randomly assigned into two intervention and control groups. Both groups at baseline will receive lifestyle modification education. The intervention period will be 12 weeks, in which the intervention group will consume two cups of sour tea extract daily between morning and evening meals for 90 days (each time, add two teaspoons (2 grams) of pulverized sour tea in one glass of boiling water (240 ml) for 30 minutes, with a sugar cube (3 g)). The Intervention group will be assessed and followed of possible complications of consuming sour tea. In both groups total cholesterol, triglyceride, LDL-c, HDL-c will be measured at baseline, and six weeks and twelve weeks after the intervention.